Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Psutka, Sarah P
ENLIGHTED, NCT04620239 / 2020-004494-41: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer () Study	Recruiting	3	100	Europe, US, RoW	padeliporfin VTP, WST11	Steba Biotech S.A., PrimeVigilance, ICON plc	Transitional Cell Cancer of Renal Pelvis and Ureter	12/24	01/29
Loidl, Wolfgang
ENLIGHTED, NCT04620239 / 2020-004494-41: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer () Study	Recruiting	3	100	Europe, US, RoW	padeliporfin VTP, WST11	Steba Biotech S.A., PrimeVigilance, ICON plc	Transitional Cell Cancer of Renal Pelvis and Ureter	12/24	01/29